Relationship of β2-microglobulin to arterial stiffness in Japanese subjects

Hypertension Research

Volumn 28, Issue 6, 2005, Pages 505-511

  Saijo, Yasuaki ^a   Utsugi, Megumi ^a   Yoshioka, Eiji ^a   Horikawa, Naoko ^a   Sato, Tetsuro ^a   Gong, Yingyan ^a   Kishi, Reiko ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

2 microglobulin; Arterial stiffness; C reactive protein; Glomerular filtration rate; Pulse wave velocity

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ADULT; ANKLE BRACHIAL INDEX; ARTERY; ARTICLE; ATHEROSCLEROSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; JAPAN; MALE; PATHOGENESIS; PREDICTION; PULSE WAVE; RIGIDITY; RISK FACTOR; ARTERIOSCLEROSIS; BLOOD; BLOOD FLOW VELOCITY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PULSATILE FLOW; STATISTICAL MODEL;

ADULT; ARTERIOSCLEROSIS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PULSATILE FLOW; RISK FACTORS;

EID: 23944444787     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.28.505     Document Type: Article

References (43)

1. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
2. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843.
3. Koenig W, Sund M, Frohlich M, et al: C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-242.
4. Danesh J, Whincup P, Walker M, et al: Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199-204.
5. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
6. Bethea M, Forman DT: Beta 2-microglobulin: its significance and clinical usefulness. Ann Clin Lab Sci 1990; 20: 163-168.
7. Winchester JF, Salsberg JA, Levin NW: Beta-2 microglobulin in ESRD: an in-depth review. Adv Ren Replace Ther 2003; 10: 279-309.
8. Ullum H, Lepri AC, Katzenstein TL, et al: Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels. Scand J Infect Dis 2000; 32: 371-376.
9. Diem H, Fateh-Moghadam A, Lamerz R: Prognostic factors in multiple myeloma: role of beta 2-microglobulin and thymidine kinase. Clin Investig 1993; 71: 918-923.
10. Sadamori N, Mine M, Hakariya S, et al: Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia. Leukemia 1995; 9: 594-597.
11. Castro J, Jimenez-Alonso J, Sabio JM, et al, Grupo Lupus Virgen de las Nieves: Salivary and serum beta2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjogren syndrome and Sjogren syndrome secondary to systemic lupus erythematosus. Clin Chim Acta 2003; 334: 225-231.
12. Jovanovic D, Krstivojevic P, Obradovic I, Durdevic V, Dukanovic L: Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate. Ren Fail 2003; 25: 123-133.
13. Lehmann ED: Clinical value of aortic pulse-wave velocity measurement. Lancet 1999; 354: 528-529.
14. Asmar R, Benetos A, Topouchian J, et al: Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485-490.
15. Laurent S, Katsahian S, Fassot C, et al: Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003; 34: 1203-1206.
16. Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
17. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992.
18. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
19. DuBois D, DuBois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-871.
20. Yamashina A, Tomiyama H, Takeda K, et al: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
21. Yamashina A, Tomiyama H, Arai T, et al: Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res 2003; 26: 615-622.
22. Tomiyama H, Yamashina A, Arai T, et al: Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement - a survey of 12517 subjects. Atherosclerosis 2003; 166: 303-309.
23. Saijo Y, Utsugi M, Yoshioka E, et al: Relationship of Helicobacter pylori infection to arterial stiffness in Japanese subjects. Hypertens Res 2005; 28: 283-292.
24. Okamura T, Moriyama Y, Kadowaki T, Kanda H, Ueshima H: Non-invasive measurement of brachial-ankle pulse wave velocity is associated with serum C-reactive protein but not with α-tocopherol in Japanese middle-aged male workers. Hypertens Res 2004; 27: 173-180.
25. Yasmin, McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB: C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004; 24: 969-974.
26. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.
27. Mourad JJ, Pannier B, Blacher J, et al: Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001; 59: 1834-1841.
28. Chiou YY, Chiu NT, Chen MJ, Cheng HL: Role of beta 2-microglobulinuria and microalbuminuria in pediatric febrile urinary tract infection. Acta Paediatr Taiwan 2001; 42: 84-89.
29. Vraetz T, Ittel TH, van Mackelenbergh MG, Heinrich PC, Sieberth HG, Graeve L: Regulation of beta2-microglobulin expression in different human cell lines by proinflammatory cytokines. Nephrol Dial Transplant 1999; 14: 2137-2143.
30. Mogi M, Otogoto J, Ota N, Inagaki H, Minami M, Kojima K: Interleukin 1 beta, interleukin 6, beta 2-microglobulin, and transforming growth factor-alpha in gingival crevicular fluid from human periodontal disease. Arch Oral Biol 1999; 44: 535-539.
31. Azocar J, Essex M, Watson A, Gazit E, Anderson D, Yunis EJ: Changes in the expression of HLA and beta 2-microglobulin by cultured lymphoid cells. Hum Immunol 1982; 5: 283-293.
32. Cooper EH, Forbes MA, Hambling MH: Serum beta 2-microglobulin and C reactive protein concentrations in viral infections. J Clin Pathol 1984; 37: 1140-1143.
33. Grahame-Clarke C, Chan NN, Andrew D, et al: Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 2003; 108: 678-683.
34. Mori M, Terui Y, Ikeda M, et al: Beta(2)-microglobulin identified as an apoptosis-inducing factor and its characterization. Blood 1999; 94: 2744.
35. Min R, Li Z, Epstein J, Barlogie B, Yi Q: Beta(2)-microglobulin as a negative growth regulator of myeloma cells. Br J Haematol 2002; 118: 495-505.
36. Xie J, Yi Q: Beta2-microglobulin as a potential initiator of inflammatory responses. Trends Immunol 2003; 24: 228-229.
37. Esposito K, Pontillo A, Di Palo C, et al: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799-1804.
38. Okita K, Nishijima H, Murakami T, et al: Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol 2004; 24: 1868-1873.
39. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H: Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003; 167: 73-79.
40. Albert MA, Glynn RJ, Ridker PM: Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003; 107: 443-447.
41. Poortmans JR, Blommaert E, Baptista M, De Broe ME, Nouwen EJ: Evidence of differential renal dysfunctions during exercise in men. Eur J Appl Physiol Occup Physiol 1997; 76: 88-91.
42. Munakata M, Ito N, Nunokawa T, Yoshinaga K: Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653-657.
43. Kobayashi K, Akishita M, Yu W, Hashimoto M, Ohni M, Toba K: Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis 2004; 173: 13-18.